Skip to main content
Premium Trial:

Request an Annual Quote

Celera Gets $900K From NIH to Develop Avian Flu Dx; Abbott to Sell Assay

NEW YORK (GenomeWeb News) – Celera Genomics today said it has received $900,000 from the US National Institutes of Health to develop and commercialize an in vitro diagnostic for detect the A/H5 influenza virus.
 
Celera said it plans to develop the test using the primer, probe set, and protocols used by US Health and Human Services' Centers for Disease Control and Prevention, whose IP was recently cleared by the US Food and Drug Administration.
 
Celera said it will license the CDC’s H5N1 assay information and sell the test through its alliance with Abbott.
 
Celera said it expects the test to run on Abbott's new m2000 system for detecting and monitoring infectious diseases and use automated real-time PCR technology from Applied Biosystems.
 
The m2000 is currently available in Europe with CE Mark certification and is pending 510(k) clearance with the FDA.
 
The CDC’s assay is the only FDA-cleared test that detects the H5N1 virus, and its use is limited to labs designated by the Laboratory Response Network, Celera said.

The Scan

Dropped Charges

The US Justice Department has dropped visa fraud charges against five Chinese researchers, according to the Wall Street Journal.

More Kids

The Associated Press says Moderna is expanding its SARS-CoV-2 vaccine study to included additional children and may include even younger children.

PNAS Papers on Rat Clues to Human Migration, Thyroid Cancer, PolyG-DS

In PNAS this week: ancient rat genome analysis gives hints to human migrations, WDR77 gene mutations in thyroid cancer, and more.

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.